Skip to main content
Figure 11 | Head & Face Medicine

Figure 11

From: The use of botulinum toxin in head and face medicine: An interdisciplinary field

Figure 11

Patient example, intrinsic rhinitis ( ordinate : time/weeks ; abscissa : per cent (%) of pre-treatment average values (for tissue consumption : number of used tissues, for secretion : subjective patient's scoring from 1–4) : After BTA treatment (sponge technique) a dramatic improvement of symptoms is to recognize. Sneezing (A), tissue consumption (B) and nasal secretion (C) are clearly reduced. The documentation of the parameters mentioned begins 2 weeks before BTA treatment in a so called "nose diary".

Back to article page